Peer2Peer: Psychiatry (Anxiety, Depression, Schizophrenia)

Name: Peer2Peer: Psychiatry (Anxiety, Depression, Schizophrenia)
Start: 2025-01-23T19:00:00+00:00
End: 2025-01-23T20:30:00+00:00

23rd Jan 2025

7:00 - 8:30pm (GMT)

Psychiatry

23rd Jan 2025

7:00 - 8:30pm (GMT)

Hosted on MedAll

Attendance certificate available

This event has ended. Similar events

Free

ONLINE

Catch-up content

Description

Branching out from internal medicine specialties, we are expanding our lecture series to cover a range of other specialties which are assessed in the UKMLA. The next of these talks is given by Dhisala Gamage, one of our final year medical student's here at Queen's University Belfast, where she will give an in depth overview of psychiatry. She will focus on anxiety, depression and schizophrenia. The case-led session should provide students with an opportunity to test and expand on their knowledge.

Summary

Expand your expertise beyond internal medicine with our Peer2Peer lecture series, now covering specialties assessed in the UKMLA. Join Dhisala Gamage, a final-year medical student from Queen's University Belfast, as she provides a comprehensive overview of psychiatry with a focus on anxiety, depression, and schizophrenia. This case-led session is an excellent chance for medical professionals to deepen their understanding and enhance their knowledge in these crucial areas. Don't miss this unique learning opportunity!

Generated by MedBot

Learning objectives

To develop an in-depth understanding of the characteristics, diagnosis, and treatment of anxiety, depression, and schizophrenia.
To understand the various challenges and common misconceptions associated with mental health illnesses such as anxiety, depression, and schizophrenia.
To acquire practical skills in managing patients suffering from anxiety, depression, and schizophrenia using real-life case studies.
To identify and discuss the underlying causes and triggering factors of anxiety, depression, and schizophrenia in order to devise prevention strategies.
To assess the role and effectiveness of various treatment interventions in the management of patients with anxiety, depression, and schizophrenia, including pharmacological and therapeutic options.

Generated by MedBot

33 people attended this event. Sign up today and join your colleagues at future events.

Speaking at this event

View all